billHR8569Event Wednesday, April 29, 2026Analyzed

No Bias in the Baseline Act

Neutral

Summary

The No Bias in the Baseline Act (HR8569) is an early-stage procedural bill in the 119th Congress that would amend baseline budget calculations, but it authorizes no funding and affects no specific companies or sectors in a market-relevant way.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.HR8569 is a procedural budget rule change with zero funding or market impact.
  • 2.No specific tickers or sectors are affected by this bill.
  • 3.The bill has no legislative momentum — zero cosponsors and stuck in committee.

Market Implications

No market implications. The bill is procedural and does not impact any industry or company. Investors should ignore this legislation.

Full Analysis

What happened: On April 29, 2026, Rep. Cline (R-VA) introduced HR8569, which was referred to the House Budget Committee. The bill amends the Balanced Budget and Emergency Deficit Control Act of 1985 to clarify that budget baselines must assume continuation of current discretionary appropriations and prohibits inflation adjustments in baseline projections. This is a procedural budget rule change, not a spending bill. The money trail: HR8569 authorizes zero funding. It does not allocate money to any program, agency, or sector. It modifies how Congressional Budget Office (CBO) baselines are calculated, which could affect future budget debate but has no immediate market impact. Convergence: No related signals, live procurements, or presidential actions are provided. The single related bill (S4372) is an identical Senate companion, indicating bipartisan drafting but no momentum — both bills remain in committee with zero cosponsors. Structural winners and losers: None. This bill is procedural and does not create revenue streams, obligations, or regulatory changes for any publicly traded company. Timeline: The bill is in early committee stage. For market impact, it would need to pass both chambers and be signed — unlikely to advance in this Congress given no cosponsors or committee leadership support.

Key Legislators

Rep. Cline, Ben [R-VA-6]

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →